SpicyIP

JUNE 25, 2024

The latest settlement order dated 18th June 2024, authored by Justice R.I. The latest settlement not only puts an end to the immediate litigation but also builds upon crucial prior judgments that have shaped the frameworks and discourse for digital streaming platforms, commonly known as OTT platforms, in India.

Copyright 45

Copyright Settlement Television Music 45

IP and Legal Filings

APRIL 23, 2024

After he was compelled to pay his debts in 1809, the settlement stated that he would be responsible for the expenditures of maintaining a police force in the region, which he lost control of in 1819. viii] Amar Nath Jha, “Locating The Ancient History Of Santal Parganas” 70 Proceedings of the Indian History Congress 187 (2009-2010).

Publishing 105

Publishing Settlement Ownership Business 105

Kluwer Copyright Blog

MAY 11, 2023

The relevant act, seeking to bring Ireland in line with the Directive, is the Statutory Instrument 567/2021 ‘European Union (Copyright and Related Rights in the Digital Single Market) Regulations 2021’ (hereinafter ‘ the Regulations’ ). The Irish legislative transposition finally became law on 19 November 2021.

Copying 105

Copying Copyright Law Copyright Social Media 105

Patently-O

OCTOBER 5, 2021

and foreign patents you hold; the number of patents you have licensed or sold; and the number of patent cases you have been involved in since the Supreme Court’s decision in Bilski in 2010. marketing; h. Additionally, if you are a patent owner or inventor, please include the number of U.S. Topics for Public Comment.

Patent 102

Patent Intellectual Property Invention Inventor 102

The IPKat

SEPTEMBER 12, 2021

Abbott has two CGM devices on the market - the Freestyle Libre 1 and Libre 2 - which Abbott claims is the top selling CGM product in the world, used by 3 million people in 50 countries. With a more expensive product than Abbott's, Dexcom has a much smaller UK market share. Libre 2 was launched in October 2020.

Litigation 98

Litigation Patent Marketing Marketing 98

Bio Law Blog

JANUARY 8, 2020

The Biologics Price Competition and Innovation Act of 2009 (BPCIA) was passed as part of health reform signed into law by President Obama in March 2010. In particular, after March 23, 2020 , a marketing application for a biological product that historically could have been submitted under Section 505 of the FD&C Act (e.g.,

Marketing 40

Marketing Marketing Settlement Litigation 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. January 2021. off ASP and 23.7%

Settlement 52

Settlement Litigation Marketing Marketing 52

LexBlog IP

JANUARY 17, 2024

Financial Market Utilities This exemption includes any financial market utility designated by the Financial Stability Oversight Council under Section 804 of the Payment, Clearing, and Settlement Supervision Act of 2010.

Reporting 52

Reporting Ownership Business Government 52

Fish & Richardson Trademark & Copyright Thoughts

MARCH 8, 2021

The abbreviated biosimilar licensure pathway created by the Biologics Price Competition and Innovation Act (BPCIA) in 2010 was designed to increase competition for biologics and reduce healthcare costs. 1, 2020 and regulates anticompetitive patent settlements. BI pointed to Humira (adalimumab) as an example.

Settlement 40

Settlement Licensing Design Designs 40

LexBlog IP

AUGUST 29, 2023

Financial Market Utilities This exemption includes any financial market utility designated by the Financial Stability Oversight Council under Section 804 of the Payment, Clearing, and Settlement Supervision Act of 2010.

Reporting 52

Reporting Ownership Business Government 52

SpicyIP

MARCH 11, 2024

First, it argued that the plaintiff concealed material information that the registration of its mark was removed for non renewal in 2010 and was renewed only in 2019. Kewal Krishan Bansal vs Puneet Chhabra Propreitor on 27 February, 2024 (Delhi High Court) The defendant sought vacation of an ex-parte ad interim injunction on three grounds.

Trademark 59

Trademark Registration Copyright Patent 59

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The biosimilar market also exhibited continued growth, with multiple biosimilar developers reporting strong sales of biosimilars through 2021. With respect to commercial launches, the United States saw fewer new biosimilars entering the market in 2021 than in previous years. No earlier than 2023 per settlement. Introduction.

Litigation 52

Litigation Settlement Patent Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 5, 2022

Patent and Trademark Office (“USPTO”), climbing from 3,773 in 2010 to 5,319 in 2019 (see Figure 1). But as more players enter the market and obtain patent protection for their innovations, IP disputes among competitors are heating up. higher energy density), and more durable than lithium-ion batteries.

Intellectual Property 52

Intellectual Property Technology Journalism IP 52

IP and Legal Filings

OCTOBER 23, 2024

However, in the era of global market and globalisation, it is only a matter of fact to copy a brand’s name and mark for one’s own company. “A A typical scenario is for a squatter to register the trademark of a foreign brand and wait until the foreign brand owner enters the local market.” [5] by Act 40 of 2010, s.

Trademark 87

Trademark Registration Brands Branding 87